Anisomycin, an Inhibitor of Protein Synthesis, Overcomes TRAIL Resistance in Human Hepatocarcinoma Cells via Caspases Activation and Bid Downregulation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.